News

The companies expect to recruit around 50 male and female patients suffering from Fabry disease and who are presently receiving ERT treatment, and who have a genetic mutation

In the trial, NBTXR3 will be given to the patients before surgery by a single intra-tumoral injection followed by standard radiotherapy procedure. The primary endpoints of the clinical

The treatment of the patient follows recommendation from an independent Data Safety Monitoring Board (DSMB) to advance the investigation of a higher dose of ReN001, based on its

Argatroban injection is also indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI). The Medicines Company senior vice president

Naturex manufactures natural speciality ingredients for the Personal Care, Nutrition & Health and Food & Beverage industries. Naturex has 11 production units located in Europe (France, Italy, Spain,

The multi-dose randomized Phase 2 study enrolled approximately 52 patients in clinical sites in the US, Canada, Jamaica, Egypt and Lebanon. The study aims to investigate the safety

Pharmacyclics’ net loss was $10.96m for the fourth quarter ended 30 June 2011, compared to $6.84, for the same period in 2010. The company’s loss from operations were

Exonhit has reported net loss of EUR4.6m for the six months ended 30 June 2011, compared to EUR1.09m for the same period in 2010. For the six months

Avedro’s KXL, VibeX and Keraflex are CE marked and are commercially available outside of the US. Currently, the company has filed an additional application for orphan drug designation